R
Rodolfo Sacco
Researcher at University of Foggia
Publications - 164
Citations - 4135
Rodolfo Sacco is an academic researcher from University of Foggia. The author has contributed to research in topics: Hepatocellular carcinoma & Sorafenib. The author has an hindex of 28, co-authored 163 publications receiving 3137 citations. Previous affiliations of Rodolfo Sacco include National Institutes of Health & Seconda Università degli Studi di Napoli.
Papers
More filters
Journal ArticleDOI
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases
Barbara Coco,Filippo Oliveri,Am Maina,Pietro Ciccorossi,Rodolfo Sacco,Piero Colombatto,Ferruccio Bonino,Maurizia Rossana Brunetto +7 more
TL;DR: In this paper, transient elastography (FibroScan®) is used as a surrogate marker of fibrosis in chronic viral hepatitis patients, provided that its relationship with major changes of biochemical activity is taken into account.
Journal ArticleDOI
Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Rodolfo Sacco,Irene Bargellini,M. Bertini,Elena Bozzi,Antonio Romano,Pasquale Petruzzi,E. Tumino,Barbara Ginanni,Graziana Federici,Roberto Cioni,Salvatore Metrangolo,M. Bertoni,Giampaolo Bresci,Giuseppe Fabio Parisi,Emanuele Altomare,A. Capria,Carlo Bartolozzi +16 more
TL;DR: Conventional chemoembolization and DEB chemoEmbolization have a limited impact on liver function on short- and long-term follow-up and are associated with favorable clinical outcomes.
Journal ArticleDOI
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
Alessandro Vitale,Patrizia Burra,Anna Chiara Frigo,Franco Trevisani,Fabio Farinati,Gaya Spolverato,Michael L. Volk,Edoardo G. Giannini,Francesca Ciccarese,Fabio Piscaglia,Gian Lodovico Rapaccini,Mariella Di Marco,Eugenio Caturelli,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Antonio Gasbarrini,Rodolfo Sacco,Francesco Giuseppe Foschi,Gabriele Missale,Filomena Morisco,Gianluca Svegliati Baroni,Roberto Virdone,Umberto Cillo +24 more
TL;DR: Resection could result in survival benefit over LRT for HCC patients regardless of their BCLC stage, provided that liver dysfunction (Child B or MELD>9) and PST>1 are absent.
Journal ArticleDOI
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
Alessandro Cucchetti,Franco Trevisani,A. Pecorelli,Virginia Erroi,Fabio Farinati,Francesca Ciccarese,Gian Lodovico Rapaccini,Mariella Di Marco,Eugenio Caturelli,Edoardo G. Giannini,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Antonio Gasbarrini,Rodolfo Sacco,Francesco Giuseppe Foschi,Gabriele Missale,Filomena Morisco,Gianluca Svegliati Baroni,Roberto Virdone,Mauro Bernardi,Antonio Daniele Pinna +22 more
TL;DR: Lead-time bias is the main determinant of the short-term benefit provided by surveillance for HCC, but this benefit becomes factual in a long-term perspective, confirming the clinical utility of an anticipated diagnosis of HCC.
Journal ArticleDOI
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma
Fabio Farinati,Alessandro Vitale,Gaya Spolverato,Timothy M. Pawlik,T. Huo,Yun Hsuan Lee,Anna Chiara Frigo,A. Giacomin,Edoardo G. Giannini,Francesca Ciccarese,Fabio Piscaglia,Gian Lodovico Rapaccini,Mariella Di Marco,Eugenio Caturelli,Marco Zoli,Franco Borzio,Giuseppe Cabibbo,Martina Felder,Rodolfo Sacco,Filomena Morisco,Elisabetta Biasini,Francesco Giuseppe Foschi,Antonio Gasbarrini,Gianluca Svegliati Baroni,Roberto Virdone,Alberto Masotto,Franco Trevisani,Umberto Cillo +27 more
TL;DR: The ITA.LI.CA prognostic system shows a strong ability to predict individual survival in European and Asian populations and showed optimal discrimination and calibration abilities in Italian patients.